IFNG and breast carcinoma: Ch/γ-PGA NPs have demonstrated synergistic effects with conventional radiotherapy in reducing systemic immunosuppression and tumor progression in 4T1 breast cancer models (Castro et al., 2020[16]), suggesting their potential as adjuvants for IFN-γ-based therapies.